|
|
-
PRAS40 hyperexpression promotes hepatocarcinogenesis (vol 51, 102604, 2020)
- Qi, Zhaolai; Zhang, Ting; Song, Lei; Fu, Hongyong; Luo, Haifeng; Wu, Jie; Zhao, Shuyun; Zhang, Tianhua; Guo, Lianying; Jin, Lingling; Zhang, He; Huang, Gena; Ma, Tonghui; Wu, Yingjie; Huang, Lin*
- EBioMedicine, 2020, 60: 103001.
-
|
下载全文
-
PRAS40 hyperexpression promotes hepatocarcinogenesis.
- Qi, Zhaolai; Zhang, Ting; Song, Lei; Fu, Hongyong; Luo, Haifeng; Wu, Jie; Zhao, Shuyun; Zhang, Tianhua; Guo, Lianying; Jin, Lingling; Zhang, He; Huang, Gena; Ma, Tonghui; Wu, Yingjie; Huang, Lin
- EBioMedicine, 2020, 51: 102604.
-
|
|
|
-
Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib.
- Ding, Jinlei; Yao, Yating; Huang, Gena; Wang, Xiaonan; Yi, Jingyan; Zhang, Nan; Liu, Chongya; Wang, Kainan; Zhang, Yuan; Wang, Min; Liu, Pixu*; Ye, Mingliang*; Li, Man*; Cheng, Hailing*
- Cancer Letters, 2020, 475: 53-64.
-
|
-
RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness.
- Huang, Gena; Song, Chen; Wang, Ning; Qin, Tao; Sui, Silei; Obr, Alison; Zeng, Li; Wood, Teresa L; LeRoith, Derek; Li, Man; Wu, Yingjie
- Carcinogenesis, 2020, 41(9): 1294-1305.
-
|
![]()
下载全文
-
Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1.
- Qin, Tao*; Huang, Gena*; Chi, Liyuan; Sui, Silei; Song, Chen; Li, Na; Sun, Siwen; Li, Ning; Zhang, Min; Zhao, Zuowei*; Li, Lianhong*; Li, Man*
- Biomedicine & Pharmacotherapy, 2017, 95: 649-655.
-
|
科研之友
微信
新浪微博
Facebook
分享链接
